Valemetostat New Drug Application Submitted in Japan for Treatment of Patients with Adult T-Cell Leukemia/Lymphoma
Submission of Orphan Drug designated valemetostat based on pivotal phase 2 trial in patients with relapsed/refractory ATL Fifth potential medicine...







